Market Research Report
Defibrillators - Global Market Outlook (2017-2023)
|Published by||Stratistics Market Research Consulting||Product code||599843|
|Published||Content info||170 Pages
Delivery time: 2-3 business days
|Defibrillators - Global Market Outlook (2017-2023)|
|Published: November 1, 2017||Content info: 170 Pages||
According to Stratistics MRC, the Global Defibrillators market is accounted for $12.39 billion in 2016 and is expected to reach $22.35 billion by 2023 growing at a CAGR of 8.8%. The defibrillation is a procedure comprising of delivering an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse during cardiac arrest. Technological advancement of defibrillators, geriatric population with high risk of target diseases and increasing number of training and awareness programs across the globe are proliferating the market. However, product failures & recalls and lack of awareness about sudden cardiac arrest (SCA) are the factors inhibiting the market.
By end users, hospital segment dominated the global market owing to modifying policies by governments of developed countries. As, implantable devices are mostly accessible in hospitals there is significant contribution to the growth of external and implantable devices. Most of the hospitals are necessarily to be equipped with external as well as implantable defibrillators.
Based on geography, Asia-Pacific region is expected to be the fastest-growing region owing to large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.
Some of the key players in global Defibrillators market include HeartSine Technologies, LLC., GE Healthcare, Fukuda Denshi Co., LTD., Defibtech LLC, Cardiac Science Corporation, Boston Scientific Corporation, Access Cardio Systems, Philips Healthcare, Nihon Kohden Corporation, Koninklijke Philips N.V., BIOTRONIC SE & Co. KG, Metrax, Medtronic Inc., LivaNova, Physio-Control Inc., Zoll Medical Corporation, Welch Allyn, St. Jude Medical LLC, Sorin Group, Schiller AG and Progetti S.R.I.
End Users Covered:
What our report offers: